WallStreetZenWallStreetZen

NASDAQ: PRFX
Painreform Ltd Stock

$0.50+0.03 (+6.38%)
Updated Jun 5, 2023
PRFX Price
$0.50
Fair Value Price
$1.13
Market Cap
$5.36M
52 Week Low
$0.34
52 Week High
$1.29
P/E
-0.57x
P/B
0.6x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$9.41M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.17
Operating Cash Flow
-$7M
Beta
0.78
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PRFX Overview

PainReform Ltd. develops reformulations of established pain therapeutics. Its PRF-110 product is a viscous clear oil-based solution instilled directly into surgical wounds to provide localized and extended post-operative analgesia. PRF-110 is in clinical trials related to bunionectomy surgeries and hernia repairs. PainReform was incorporated in 2007 and is headquartered in Tel Aviv, Israel.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRFX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRFX ($0.50) is undervalued by 55.77% relative to our estimate of its Fair Value price of $1.13 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRFX ($0.50) is significantly undervalued by 55.77% relative to our estimate of its Fair Value price of $1.13 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PRFX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRFX due diligence checks available for Premium users.

Be the first to know about important PRFX news, forecast changes, insider trades & much more!

PRFX News

Valuation

PRFX fair value

Fair Value of PRFX stock based on Discounted Cash Flow (DCF)
Price
$0.50
Fair Value
$1.13
Undervalued by
55.77%
PRFX ($0.50) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRFX ($0.50) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRFX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRFX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.57x
Industry
14.98x
Market
53.21x

PRFX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.6x
Industry
1.78x
PRFX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRFX's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.3M
Profit Margin
0%
PRFX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$10.4M
Liabilities
$1.5M
Debt to equity
0.17
PRFX's short-term assets ($10.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRFX's short-term assets ($10.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRFX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.0M
Investing
$6.0M
Financing
$0.0
PRFX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRFX vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
PRFX$5.36M+6.38%-0.57x0.60x
EVOK$5.40M-2.42%-0.64x2.54x
YCBD$5.42M-2.06%-0.05x0.21x
PTPI$5.22M+0.82%-0.24x0.34x
SNOA$4.33M-3.62%-0.40x0.78x

Painreform Stock FAQ

What is Painreform's quote symbol?

(NASDAQ: PRFX) Painreform trades on the NASDAQ under the ticker symbol PRFX. Painreform stock quotes can also be displayed as NASDAQ: PRFX.

If you're new to stock investing, here's how to buy Painreform stock.

What is the 52 week high and low for Painreform (NASDAQ: PRFX)?

(NASDAQ: PRFX) Painreform's 52-week high was $1.29, and its 52-week low was $0.34. It is currently -61.18% from its 52-week high and 47.06% from its 52-week low.

How much is Painreform stock worth today?

(NASDAQ: PRFX) Painreform currently has 10,721,131 outstanding shares. With Painreform stock trading at $0.50 per share, the total value of Painreform stock (market capitalization) is $5.36M.

Painreform stock was originally listed at a price of $6.74 in Sep 1, 2020. If you had invested in Painreform stock at $6.74, your return over the last 2 years would have been -92.58%, for an annualized return of -72.76% (not including any dividends or dividend reinvestments).

How much is Painreform's stock price per share?

(NASDAQ: PRFX) Painreform stock price per share is $0.50 today (as of Jun 5, 2023).

What is Painreform's Market Cap?

(NASDAQ: PRFX) Painreform's market cap is $5.36M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Painreform's market cap is calculated by multiplying PRFX's current stock price of $0.50 by PRFX's total outstanding shares of 10,721,131.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.